First US Patient Treated in Phase 3 Trial of Cord Blood Stem Cell Therapy for Knee Osteoarthritis
Key detailsThe condition: Osteoarthritis affected over 528 million people worldwide in 2019, and the knee is one of the joints most commonly affected – with a prevalence of 365 million [1]. There is no cure, and current treatment manages symptoms rather than repairing...
Could a Blood Test at 12 Weeks Predict Pre-eclampsia?
Key detailsThe condition: Pre-eclampsia affects around one in 20 pregnancies worldwide and, together with fetal growth restriction, is a major cause of stillbirth and of illness in mothers and newborns [1, 2].The discovery: Cambridge scientists found that low levels...
Could Sibling Cord Blood Help a Child With Cerebral Palsy?
Key detailsThe condition: Around 1 in 500 babies born globally has cerebral palsy, a lifelong condition that affects movement and coordination [1, 2].The story: Gabriel Machado, a teenager from Lexington, Massachusetts, has been accepted onto a Duke University...
Cord Tissue Stem Cell Therapy for Pulmonary Fibrosis Completes First Human Safety Trial
Key details The condition: Idiopathic pulmonary fibrosis is a progressive scarring disease of the lungs that mainly affects older adults. Thousands of people are newly diagnosed in the UK each year, and studies of health records show the condition is becoming more...
Cord Blood Cell Therapy for Motor Neurone Disease Granted FDA Fast Track Status
Key detailsThe condition: It is estimated 35,000 people in the US have ALS, with 5,000 people being diagnosed annually [1].The news: The US Food and Drug Administration (FDA) has granted Fast Track status to CK0803, an experimental cell therapy for amyotrophic lateral...
Recent Posts
-
How Long Can Stem Cells Stay Frozen? New Study Finds Cells Still Working After 13 Years
-
First US Patient Treated in Phase 3 Trial of Cord Blood Stem Cell Therapy for Knee Osteoarthritis
-
Could a Blood Test at 12 Weeks Predict Pre-eclampsia?
-
Could Sibling Cord Blood Help a Child With Cerebral Palsy?
-
Cord Tissue Stem Cell Therapy for Pulmonary Fibrosis Completes First Human Safety Trial
